Discover the course
WEBINAR: Patient Support Program (PSP)
Strategies, limitations and experiences of a PSP
In recent years, Patient Support Programs (PSPs) are playing an increasingly strategic role within the business model of the pharma and medical device industry. Indeed, they have become part of the current debates on new care models able to guarantee the sustainability of the healthcare system.
Patient Support Programs have been recognized as important tools to help patients managing their disease, and to rationalize the resources available; regardless these are devoted to therapeutic adherence, health education, lifestyle support or any other form of chronic disease support.
- How can we implement a business strategy that can bring all the benefits deriving from the Patient Support Program into the system?
- Which company roles are involved?
- What are the DOs & DON'Ts and how can we implement a Patient Support Program?
These are just some questions that this course intends to address.
- Patient Support Programs as a strategic lever in the positioning of the pharma and device industry
- Patient Support Program - Regulatory framework and legislative boundaries
- From the concept to the management of a Patient Support Program
- Digital Patient Support Programs
- The use of the data collected through Patient Support Programs
- Cross-functionality and trans-nationality of the Patient Support Programs
- Testimony: Experience of a Patient Support Program by the pharmaceutical company
The course will be in Italian
After his studies he obtained an MBA in Business Administration in 1998. Afterwards, he worked as consultant in the field of organizational design, in the Business Process Re-engineering and in the definition of management control systems for around 10 years. He then focused on the world of healthcare in which he has been operating for more than 10 years, managing and implementing Patient Support Programs in multiple therapeutic areas. Since 2011 he works as an Operation Manager in Healthcare Network Partners (HNP) dealing with customer relationship management, managing the launch of new projects, and continuously improving services and programs.
Ha all’attivo quasi 30 anni vissuti in vari ambiti del mondo farmaceutico, dapprima nella sperimentazione clinica, poi nel regolatorio e infine nel market access, in cui conta ormai 20 anni di esperienza. Negli ultimi 15 anni si è dedicata in particolare al mondo delle malattie rare. Nel 2012 ha fondato la società di consulenza RAReg – di cui è managing director – con un focus specifico su tutti gli aspetti regolatori e farmacoeconomici dell’accesso ai farmaci, dal cui successo dipende la possibilità, per i pazienti italiani, di poter fruire di terapie sicure, efficaci e innovative.
After his studies, he obtained a master’s degree in Information Security Management in 2005 and an Executive Master’s degree in Digital Transformation & Business Strategy in 2018. He has worked in the world of Information Technology for more than 20 years. Before joining the Healthcare Network Partners (HNP) team he worked as a consultant for various healthcare projects. Since 2016 he has been Chief Information Officer within HNP dealing with proposing and implementing digital strategies, developing software solutions for business needs and developing technology-based business ideas.
He graduated in Engineering in 1992 and subsequently followed a Global Executive MBA at Bocconi University. He has more than 20 years of experience in healthcare and has been in the world of Patient Support Programs for more than 10 years. Since 2011 he works as Business & Innovation Manager in Healthcare Network Partners (HNP) dealing with business development, internationalization and innovative business models.
After graduating in Law, in 2013 she qualified to practice the legal profession. She has been collaborating with the Astolfi e Associati law firm since 2014 where she mainly deals with pharmaceutical and health law, also addressing issues relating to the advertising of medicines and medical devices. She is also a member of the editorial board: “Review of pharmaceutical and health law”.
The course is designed for those who approach the world of Patient Support Programs and are responsible of the strategic coordination and operational management of PSP.
It addresses the management of pharmaceutical / medical device companies that operate mainly in these areas:
- Patient Engagement, Patient Experience and Patient Advocacy
- Patient support program manager
- Medical Affairs
- Marketing manager
- Market Access
- Regulatory Affairs
This Webinar online in divided in 4 modules:
Early Bird: € 840,00* (until 28 May 2020)
Ordinary: € 915,00*
Freelance - Academy - Public Administration**: € 504,00*
* for Italian companies: +22% VAT
** Early Bird discount not applicable to Freelance - Academy - Public Administration fee
The fee includes: Access to the webinar, teaching materials in pdf format provided post-webinar, organizational office support, certificate of attendance.
Thursday, May 28, 2020
At the end of the training, you will be able to
Be aware of the appropriate regulatory framework
Understand the various types of Patient Support Program
Understand how to design and implement a Patient Support Program
Know what resources are involved in the process
Be aware of how to identify the Key Performance Indicators (KPI) needed to measure their effectiveness
Know the different uses of the data collected in the Patient Support Programs